EverSource Wealth Advisors’s Bioventus BVS Stock Holding History

EverSource Wealth Advisors’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.29K	Sell	243 -755	-76%	-$7.21K	﹤0.01%	3672
2026 Q1	$9.11K	Buy	998 +674	+208%	+$5.65K	﹤0.01%	2959
2025 Q4	$2.41K	Buy	324 +71	+28%	+$510	﹤0.01%	3430
2025 Q3	$1.69K	Buy	253 +24	+10%	+$167	﹤0.01%	3569
2025 Q2	$1.52K	Buy	229 +184	+409%	+$1.3K	﹤0.01%	3595
2025 Q1	$412	Buy	45 +37	+463%	+$370	﹤0.01%	3523
2024 Q4	$84	Buy	+8	New	+$95	﹤0.01%	3575

Other funds holding BVS

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

KOCAA

Knights of Columbus Asset Advisors New Haven, Connecticut $2B AUM 42.86% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

WesBanco Bank Wheeling, West Virginia $4.02B AUM 32.62% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

KPWS

Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return

CCIA

Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

SCP

Seizert Capital Partners Birmingham, Michigan $2.42B AUM 22.12% 1-Year Est. Return

EverSource Wealth Advisors's BVS Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Bioventus (BVS) stake by 76% in Q2 2026, selling an estimated $7.21K and leaving 243 shares worth $2.29K. The position accounts for ﹤0.01% of the portfolio, ranked #3672.

EverSource Wealth Advisors first reported a position in BVS in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.11K in Q1 2026. 37 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

EverSource Wealth Advisors held 243 shares of Bioventus worth $2.29K as of Q2 2026.
EverSource Wealth Advisors sold 755 Bioventus shares in Q2 2026, an estimated $7.21K.
Bioventus made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3672 holding.
EverSource Wealth Advisors first reported a position in Bioventus in Q4 2024 and has held it in 7 quarters since.
EverSource Wealth Advisors's Bioventus position peaked at $9.11K in Q1 2026.
37 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.